| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/16/1989 | US4831170 Pharmaceutically active phospino-hydrocarbon-group VIII-metal complexes, antitumor compositions containing these complexes, and a process for preparing said compounds or antitumor compositions |
| 05/16/1989 | US4831052 Flavone carboxylic acid derivatives |
| 05/16/1989 | US4831039 Isoquinoline compound |
| 05/16/1989 | US4831038 Vinblastine derivatives and pharmaceutical composition containing them |
| 05/16/1989 | US4831021 Ganglioside derivatives |
| 05/16/1989 | US4831020 Ingredient effective for activating immunity obtained from Chlorella minutissima |
| 05/16/1989 | CA1254217A1 Diaryldiazolylmethanes |
| 05/16/1989 | CA1254139A1 Pharmaceutical composition comprising a combination of at least one immunotoxin and at least one mannose-containing polymer |
| 05/10/1989 | EP0315519A2 Aminopimelic acid derivatives, process for their preparation and their use as medicines |
| 05/10/1989 | EP0315491A2 Amino-substituted pyrylium dyes and uses thereof |
| 05/10/1989 | EP0315456A2 Polysaccharide-modified immunoglobulins having reduced immunogenic potential or improved pharmacokinetics |
| 05/10/1989 | EP0315434A2 Pyridoxal hydrazone derivatives their production and use and pharmaceutical compositions containing the same |
| 05/10/1989 | EP0315367A2 Polypeptides |
| 05/10/1989 | EP0315289A2 Cell growth inhibitory factor |
| 05/10/1989 | EP0315071A2 Benzocyclohepten derivatives, their preparation and utilisation for pharmaceutics |
| 05/10/1989 | CN1032795A Linear and cyclic analogues of alpha-msh fragments with extraordinary potency |
| 05/10/1989 | CN1032741A Double-stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell |
| 05/09/1989 | US4829080 Skin disorders, psoriasis, acne |
| 05/09/1989 | CA1253871A1 Diphenylmethylimine derivatives |
| 05/09/1989 | CA1253862A1 N,n-disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo- ¬2,1-b|quinazolinyl)-oxyalkylamides |
| 05/09/1989 | CA1253859A1 10-aryl-1,8-dihydroxy-anthrones and esters thereof; process for preparing the same |
| 05/09/1989 | CA1253820A1 Cl-1577-b.sub.4 compound, its production and use |
| 05/05/1989 | WO1989003873A1 Regulation of cell proliferation and differentiation using peptides |
| 05/05/1989 | WO1989003845A1 Ps2 protein derivative |
| 05/05/1989 | WO1989003838A1 Acyl deoxyribonucleoside derivatives and uses thereof |
| 05/05/1989 | WO1989003687A1 Composition and method for treating cancers characterized by over-expression of the c-fms proto-oncogene |
| 05/05/1989 | WO1989003681A1 Substituted tetralins, chromans and related compounds in the treatment of asthma |
| 05/03/1989 | EP0314401A2 New compound WF 2015 A and B, production thereof and use thereof |
| 05/03/1989 | EP0314280A2 Process for the preparation of fused pyridine compounds |
| 05/03/1989 | EP0313997A2 Medicine, therein contained phosphor containing 2-isoxazolidines and isoxazoles, as well as process for preparing those heterocyclic compounds |
| 05/03/1989 | EP0313874A2 Disulfur analogs of LL-E33288 antitumor agents |
| 05/03/1989 | EP0313873A1 Targeted forms of methyltrithio antitumor agents |
| 05/03/1989 | EP0313724A2 Bis (acyloxymethyl) imidazole Derivative |
| 05/03/1989 | EP0313697A1 Leukotriene antagonists |
| 05/02/1989 | US4826969 Bicyclic naphthalenic derivatives, a process for preparing the same and human or veterinary medicines and cosmetic compositions containing said derivatives |
| 05/02/1989 | US4826850 Quinoline base compound, process for the preparation thereof and anticancer agent containing the same as pharmacologically efficacious component |
| 05/02/1989 | US4826837 Immunomodulators |
| 05/02/1989 | US4826823 Microbiocides, viricides |
| 04/27/1989 | DE3835099A1 Pharmazeutische zusammensetzung Pharmaceutical composition |
| 04/26/1989 | EP0313515A1 A polypeptide growth factor from milk |
| 04/26/1989 | EP0313296A2 Substituted chromans and related compounds in the treatment of asthma |
| 04/26/1989 | EP0313158A2 Gastrin releasing peptide antagonist |
| 04/26/1989 | EP0313104A2 Purification, production and use of tumor necrosis factors |
| 04/26/1989 | EP0313094A2 Anticancer agent and reagent for obtaining revertants |
| 04/26/1989 | EP0312858A1 Heterocyclic derivatives, their preparation and radiosensitizing agents and antiviral agents comprising same as their active component |
| 04/26/1989 | EP0312543A1 $i(IN SITU) ACTIVE COMPOUND ASSEMBLY |
| 04/25/1989 | US4824944 Antineoplastic enamine derivatives of daunorubicin and adriamycin |
| 04/25/1989 | US4824830 6- or 7-methylenandrosta-1,4-diene-3,17-dione derivatives and process for their preparation |
| 04/25/1989 | CA1253160A1 Pharmaceutical salts of 4'-(9-acridinylamino) methanesulfon-manisidide |
| 04/20/1989 | WO1989003429A1 Recombinant avipox virus |
| 04/20/1989 | WO1989003224A1 Product containing as active principles: a) a peptide having an activity of the type of that of human gamma interferon, b) hydroxyurea |
| 04/19/1989 | EP0312132A2 Veterinary and human medical remedy having an antiviral and antitumorous activity, containing 2,6-diamino-3-phenyl-azo-pyridine |
| 04/18/1989 | US4822879 Lower toxicity than griseolic acid itself |
| 04/18/1989 | US4822813 3-(2-Haloalkyl)-1,4-oxathiins and 2-(2-haloalkyl)-1,4-dithiins, and treatment of leukemia and tumors therewith |
| 04/18/1989 | US4822612 Anticancer agent |
| 04/18/1989 | US4822605 Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like |
| 04/18/1989 | US4822528 4-substituted 6-alkylidenandrosteine-3,17-dione derivatives and process for their preparation |
| 04/18/1989 | CA1252791A1 Benzoyl urea derivatives having anti-tumor activity |
| 04/18/1989 | CA1252789A1 Mitomycin analogs |
| 04/18/1989 | CA1252783A1 Pteridines, processes for preparing them and their use as intermediate products or as pharmaceutical compositions |
| 04/12/1989 | EP0311447A1 Aromatase inhibiting 4(5)-imidazoles |
| 04/12/1989 | EP0311138A2 Compounds for the induction of in vivo and vitro production of cytokines |
| 04/12/1989 | EP0311068A2 Polyamine derivatives as antineoplastic agents |
| 04/12/1989 | EP0311002A2 Anthracyclin derivatives, a method for their preparation and their use as a drug |
| 04/12/1989 | CN1032296A Synergistic interplay of lymphokines and dsrnas |
| 04/11/1989 | US4820873 Antitumor agents |
| 04/11/1989 | US4820824 Mitomaycin compounds |
| 04/11/1989 | US4820641 Monoclonal antibody capable of specifically distinguishing human hepato-carcinoma cells |
| 04/06/1989 | WO1989002897A1 Therapeutic peptides |
| 04/06/1989 | WO1989002746A1 Uses of recombinant colony stimulating factor-1 |
| 04/06/1989 | WO1989002734A1 Vasoconstrictive substances in combination with cytotoxic agents |
| 04/05/1989 | EP0310541A1 Antigestagenic and antioestrogenic compounds for the introduction of labour and interruption of pregnancy, as well as for the treatment of gynecologic disorders |
| 04/05/1989 | EP0310260A2 Platinum complexes and their use as anti-tumor agents |
| 04/05/1989 | EP0168478B1 Cancer chemotherapeutic cyclic and acyclic disulfonic ester compounds, method of use therefor, and intermediates |
| 04/05/1989 | EP0165289B1 Novel derivatives of guanine |
| 04/04/1989 | US4818818 Method for the preparation of 4'-0-tetrahydropyranyladriamycin b |
| 04/04/1989 | US4818765 Treating liver, respiratory tract, vascular disorders |
| 04/04/1989 | US4818752 Soluble phosphorylated glucan: methods and compositions for treatment of neoplastic diseases |
| 04/04/1989 | CA1252108A1 ( )-cyanidan-3-ol derivatives, processes for their manufacture, pharmaceutical preparations that contain such compounds, and the use of the latter |
| 04/04/1989 | CA1252085A1 Steroidic aromatase inhibitors |
| 04/04/1989 | CA1252058A1 Enzyme-inhibitory griseolic acid derivatives, and their use |
| 04/04/1989 | CA1252046A1 Methods for oncogenic detection |
| 03/29/1989 | EP0309425A2 New heterocyclic derivatives |
| 03/29/1989 | EP0309411A2 Saccharide derivatives |
| 03/29/1989 | EP0309297A2 Therapeutic peptides |
| 03/29/1989 | EP0308614A2 Anthracyclin glycoside and use of those glycosides as a drug |
| 03/29/1989 | EP0308613A2 Anthracyclinones and method for their preparation |
| 03/29/1989 | EP0308475A1 Adjuvant for certain antimitotic chemicals, obtained from vibrio cholerae |
| 03/29/1989 | CN1032009A 脲的衍生物 Urea derivatives |
| 03/28/1989 | US4816575 2'-(R)-substituted-2'-deoxyneplanocin A derivatives |
| 03/28/1989 | US4816560 Storage stability |
| 03/28/1989 | US4816485 N-phenylbenzamide derivatives |
| 03/28/1989 | US4816482 Radioprotective agents having an amino-thioalkyl structure |
| 03/28/1989 | US4816450 Antiinflammatory agents, amine compounds |
| 03/28/1989 | US4816444 Cell growth inhibitory substance |
| 03/28/1989 | US4816442 Method of inhibiting tumor growth sensitive to CIF-βtreatment |
| 03/28/1989 | US4815446 Process for treating metastasis of cancerous tumors |
| 03/28/1989 | CA1251789A1 Bis-(substituted amino) anthraquinones |
| 03/23/1989 | WO1989002276A1 Use of a tripeptide for the preparation of pharmaceutical compositions and a pharmaceutical composition and method |
| 03/22/1989 | EP0308208A1 Modified antibody conjugates with enhanced clearance |